Human Cytomegalovirus IE1 Protein Enhances Herpes Simplex Virus Type 1-induced Syncytial Formation in U373MG Cells

被引:5
作者
Shin, Ki-Chul [2 ]
Park, Chung-Gyu [1 ]
Hwang, Eung-Soo [1 ]
Cha, Chang-Yong [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul 110799, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110799, South Korea
关键词
Herpesvirus; 1; Human; Human Cytomegalovirus; IE1; Protein; Cytomegalovirus; Syncytial Formation; Roscovitine;
D O I
10.3346/jkms.2008.23.6.1046
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Co-infection of herpes simplex virus type 1 (HSV-1) and human cytomegalovirus (HCMV) is not uncommon in immunocompromised hosts. Importantly, organ transplant recipients concurrently infected with HSV-1 and HCMV have a worse clinical outcome than recipients infected with a single virus. However, factors regulating the pathologic response in HSV-1, HCMV co-infected tissues are unclear. We investigated the potential biologic role of HCMV gene product immediate early 1 (IE1) protein in HSV-1-induced syncytial formation in U373MG cells. We utilized a co-infection model by infecting HSV-1 to U373MG cells constitutively expressing HCMV IE1 protein, UMG1-2. Syncytial formation was assessed by enumerating nuclei number per syncytium and number of syncytia. HSV-1-induced syncytial formation was enhanced after 24 hr in UIVIG1-2 cells compared with U373MG controls. The amplified phenotype in UIVIG1-2 cells was effectively suppressed by roscovitine in addition to inhibitors of viral replication. This is the first study to provide histological evidence of the contribution of HCMV IE1 protein to enhanced cytopathogenic responses in active HSV-1 infection.
引用
收藏
页码:1046 / 1052
页数:7
相关论文
共 59 条
[1]   INVITRO VIRUCIDAL ACTIVITY OF SELECTED ANTHRAQUINONES AND ANTHRAQUINONE DERIVATIVES [J].
ANDERSEN, DO ;
WEBER, ND ;
WOOD, SG ;
HUGHES, BG ;
MURRAY, BK ;
NORTH, JA .
ANTIVIRAL RESEARCH, 1991, 16 (02) :185-196
[2]   A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days [J].
Benson, C. ;
White, J. ;
De Bono, J. ;
O'Donnell, A. ;
Raynaud, F. ;
Cruickshank, C. ;
McGrath, H. ;
Walton, M. ;
Workman, P. ;
Kaye, S. ;
Cassidy, J. ;
Gianella-Borradori, A. ;
Judson, I. ;
Twelves, C. .
BRITISH JOURNAL OF CANCER, 2007, 96 (01) :29-37
[3]   Plasma membrane requirements for cell fusion induced by herpes simplex virus type 1 glycoproteins gB, gD, gH and gL [J].
Browne, H ;
Bruun, B ;
Minson, T .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :1419-1422
[4]  
Cha CY, 1988, J KOR SOC MICROBIOL, V23, P505
[5]   REACTIVATION OF HERPES-SIMPLEX VIRUS TYPE-2 FROM A QUIESCENT STATE BY HUMAN CYTOMEGALO-VIRUS [J].
COLBERGPOLEY, AM ;
ISOM, HC ;
RAPP, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (11) :5948-5951
[6]   INVOLVEMENT OF AN EARLY HUMAN CYTOMEGALO-VIRUS FUNCTION IN REACTIVATION OF QUIESCENT HERPES-SIMPLEX VIRUS TYPE-2 [J].
COLBERGPOLEY, AM ;
ISOM, HC ;
RAPP, F .
JOURNAL OF VIROLOGY, 1981, 37 (03) :1051-1059
[7]   INFECTIONS WITH HERPES-SIMPLEX VIRUSES .1. [J].
COREY, L ;
SPEAR, PG .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (11) :686-691
[8]   The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0 [J].
Davido, DJ ;
Leib, DA ;
Schaffer, PA .
JOURNAL OF VIROLOGY, 2002, 76 (03) :1077-1088
[9]   Inhibition of cyclin-dependent kinases by purine analogues - Crystal structure of human cdk2 complexed with roscovitine [J].
DeAzevedo, WF ;
Leclerc, S ;
Meijer, L ;
Havlicek, L ;
Strnad, M ;
Kim, SH .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2) :518-526
[10]   Roscovitine inhibits activation of promoters in herpes simplex virus type I genomes independently of promoter-specific factors [J].
Diwan, P ;
Lacasse, JJ ;
Schang, LM .
JOURNAL OF VIROLOGY, 2004, 78 (17) :9352-9365